hsk42360
Resumen de Ensayos Clínicos
2 ensayos encontrados
Sobre hsk42360
Se está recopilando información detallada sobre este medicamento.
Categoría
Otros Medicamentos
2
Total Ensayos
2
Reclutando
0
Activo
0
Completado
475
Inscripción Total
1
Países
Centros activos para hsk42360
Centros reclutando
1 países
NCT07561554
Fase 1
Reclutando
159 pacientes
Medicamentos:
Hsk42360-na
This is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and PD of HSK42360-Na when given orally in patients with active BRAF V600 mutation locally advanced or metastatic Solid Tumors.
China
NCT06536400
Fase 1
Reclutando
316 pacientes
Medicamentos:
HSK42360
This is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and PD of HSK42360 when given orally in patients with active BRAF V600 mutation locally advanced or metastatic Solid Tumors.
China